Linezolid and Deep venous thrombosis - a phase IV clinical study of FDA data

Summary:

Deep venous thrombosis is reported as a side effect among people who take Linezolid (linezolid), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Tuberculosis.

The phase IV clinical study analyzes which people have Deep venous thrombosis when taking Linezolid. It is created by eHealthMe based on reports of 21,827 people who have side effects when taking Linezolid from the FDA, and is updated regularly.

What is Linezolid?

Linezolid has active ingredients of linezolid. It is often used in infection. eHealthMe is studying from 21,891 Linezolid users. Check the latest studies of Linezolid.

What is Deep venous thrombosis?

Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis) is found to be associated with 2,064 drugs and 2,967 conditions by eHealthMe. Check the latest studies of Deep venous thrombosis.

On Aug, 11, 2026

21,827 people reported to have side effects when taking Linezolid.
Among them, 53 people (0.24%) have Deep venous thrombosis.

Could Linezolid cause Deep venous thrombosis?

Among these 53 people:

How long have people been on Linezolid when they have Deep venous thrombosis? *

What is the gender of people who have Deep venous thrombosis when taking Linezolid? *

female: 49.02 %
male: 50.98 %

What is the age of people who have Deep venous thrombosis when taking Linezolid? *

What are other drugs people take besides Linezolid? *

What are other side effects people have besides Deep venous thrombosis? *

Anaemia (lack of blood): 17 people, 32.08%
Thrombocytopenia (decrease of platelets in blood): 15 people, 28.30%
Acute Kidney Failure: 13 people, 24.53%
Pneumonia: 12 people, 22.64%
Hypotension (abnormally low blood pressure): 12 people, 22.64%
Sepsis (a severe blood infection that can lead to organ failure and death): 11 people, 20.75%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 11 people, 20.75%
Cardiac Failure Congestive: 10 people, 18.87%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 9 people, 16.98%
Rashes (redness): 8 people, 15.09%

What are the existing conditions these people have? *

Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 10 people, 18.87%
Pain: 6 people, 11.32%
Sepsis (a severe blood infection that can lead to organ failure and death): 6 people, 11.32%
Pneumonia: 5 people, 9.43%
Constipation: 4 people, 7.55%
Multiple Myeloma (cancer of the plasma cells): 4 people, 7.55%
Cough: 4 people, 7.55%
Diabetes: 4 people, 7.55%
Fever: 4 people, 7.55%
Oedema Peripheral (superficial swelling): 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Linezolid and have Deep venous thrombosis?

- Check whether Deep venous thrombosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Linezolid:

Linezolid (21,891 reports)

Browse all side effects of Linezolid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,064 drugs)

Browse all the conditions that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,967 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on linezolid (the active ingredients of Linezolid) and Linezolid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.